Shenzhen YHLO Biotech Co., Ltd. (688575.SS)
CNY 16.47
(0.37%)
CNY 16.47
(0.37%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.27 Billion CNY | -27.98% |
| 2022 | 1.76 Billion CNY | 183.33% |
| 2021 | 623.59 Million CNY | 11.47% |
| 2020 | 559.44 Million CNY | 12.5% |
| 2019 | 497.27 Million CNY | -1.63% |
| 2018 | 505.53 Million CNY | 69.38% |
| 2017 | 298.45 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.27 Billion CNY | 0.01% |
| 2024 Q2 | 1.44 Billion CNY | 13.23% |
| 2024 Q3 | 1.48 Billion CNY | 3.24% |
| 2023 Q2 | 1.25 Billion CNY | 2.39% |
| 2023 Q1 | 1.22 Billion CNY | -30.45% |
| 2023 FY | 1.27 Billion CNY | -27.98% |
| 2023 Q4 | 1.27 Billion CNY | -2.05% |
| 2023 Q3 | 1.29 Billion CNY | 3.25% |
| 2022 Q3 | 1.13 Billion CNY | -10.66% |
| 2022 Q1 | 1.08 Billion CNY | 73.57% |
| 2022 Q2 | 1.27 Billion CNY | 17.46% |
| 2022 FY | 1.76 Billion CNY | 183.33% |
| 2022 Q4 | 1.76 Billion CNY | 55.54% |
| 2021 Q2 | 547.43 Million CNY | -8.0% |
| 2021 FY | 623.59 Million CNY | 11.47% |
| 2021 Q3 | 493.18 Million CNY | -9.91% |
| 2021 Q1 | 595.03 Million CNY | 6.36% |
| 2021 Q4 | 623.59 Million CNY | 26.44% |
| 2020 Q4 | 559.44 Million CNY | 0.0% |
| 2020 FY | 559.44 Million CNY | 12.5% |
| 2020 Q2 | 568.89 Million CNY | 0.0% |
| 2020 Q1 | - CNY | -100.0% |
| 2019 Q4 | 497.27 Million CNY | 0.0% |
| 2019 FY | 497.27 Million CNY | -1.63% |
| 2018 FY | 505.53 Million CNY | 69.38% |
| 2017 FY | 298.45 Million CNY | 0.0% |